In an effort to further address the current opioid crisis, the FDA contracted the NASEM to examine existing opioid prescribing guidelines and to help outline the type of research needed to fill the gaps in evidence.
Data from a study investigating the efficacy and safety of 6-week low-dose prednisolone in patients with painful hand osteoarthritis were presented at the 2019 ACR Annual Meeting.
Patients on long-term opioid treatment for chronic pain reported experiencing negative physical side effects, emotional distress, and degraded relationships with their primary care provider.
The use of the opioid addiction medication buprenorphine is much higher in states that expanded Medicaid under the Affordable Care Act than in those that did not expand the program.
Higher pain intensity may be associated with more condition-specific healthcare utilization and the use of opioids in patients with musculoskeletal pain.
The vast majority of orthopedic surgeons recommend prescribing a nine-day supply of around-the-clock oxycodone doses following commonly performed orthopedic surgeries.
A temporary order classifying fentanyl-like drugs as controlled substances should be enacted into law, the US Department of Justice is telling Congress.
An iPad application developed to screen for conditions that may contribute to low back pain and pain interference and deliver adapted educational materials to older adults with chronic low back pain during a clinical visit has received high utility and usability ratings.
